Development of a novel mouse model for dengue virus infection

Virology

Volumn 263, Issue 1, 1999, Pages 70-77

  An, J ^a,c   Kimura Kuroda, J ^a   Hirabayashi, Y ^a,b   Yasui, K ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c NATL INST FOR ADV INTERDISC RES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING TENDENCY; BRAIN LEVEL; CANCER CELL CULTURE; CELL TRANSPLANTATION; COMBINED IMMUNODEFICIENCY; DENGUE; DISEASE COURSE; HUMAN; HUMAN CELL; HYPERCOAGULABILITY; LIVER CELL CARCINOMA; MELENA; MOUSE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; THROMBOCYTOPENIA; UREA NITROGEN BLOOD LEVEL; VIREMIA; VIRUS LOAD;

ANIMALIA; DENGUE VIRUS; DENGUE VIRUS TYPE 2; RNA VIRUSES;

EID: 0033543978     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9887     Document Type: Article

References (30)

1. Anderson R., Wang S. L., Osiowy C., Issekutz A. C. Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J. Virol. 71:1997;4226-4232.
2. Bhamarapravati N. Pathology of dengue hemorrhagic fever. Thongcaroen P. Monograph on Dengue/Dengue Hemorrhagic Fever. 1993;72-79 WHORegional Office for Southeast Asia, New Delhi.
3. Bhamarapravati N., Tuchinda P., Boonyapaknavik V. Pathology of Thailand hemorrhagic fever: A study of 100 autopsy cases. Ann. Trop. Med. Parasit. 61:1967;500-510.
4. Bosma G. C., Custer R. P., Bosma M. J. A severe combined immunodeficiency mutation in the mouse. Nature. 301:1983;527-530.
5. Burke T. Dengue hemorrhagic fever: A pathological study. Trans. R. Soc. Trop. Med. Hyg. 62:1968;682-692.
6. Chua M. N., Molanida R., de Guzman M., Laberiza F. Prothrombin time and partial thromboplastin time as a predictor of bleeding in patients with dengue hemorrhagic fever. SE Asian J. Trop. Med. Public Health. 24:1993;141-143.
7. Eckels K. H. Dengue virus infection, vaccines and immunization strategies. Kurstak E. Control of virus diseases. 1993;343-349 Dekker, New York.
8. Garcia S., Morales R., Hunter R. F. Dengue fever with thrombocytopenia: Studies towards defining vulnerability of bleeding. Bolet. Asoc. Med. Puerto Rico. 87:1995;2-7.
9. Halstead S. B. The pathogenesis of dengue: Molecular epidemiology in infectious disease. Am. J. Epidemiol. 114:1981;632-664.
10. Hathirat P., Isarangkura P., Sichaikul T., Suvatte V., Mitrakul C. Abnormal hemostasis in dengue hemorrhagic fever. SE Asian J. Trop. Med. Public Health. 24:1993;80-85.
11. Igarashi A. Isolation of a Singh's Aedes albopictus cell clone sensitive to Dengue and Chikungunya viruses. J. Gen. Virol. 40:1978;531-544.
12. Innis B. L., Eckels K. H., Kraiselburd E., Dubois D. R., Meadors G. F., Gubler D. J., Burke D. S., Bancroft W. H. Virulence of a live dengue virus vaccine candidate, a possible new marker of dengue virus attenuation. J. Infect. Dis. 158:1988;876-880.
13. Isarangkura P., Tuchinda S. The behavior of transfused platelets in dengue hemorrhagic fever. SE Asian J. Trop. Med. Public Health. 24:1993;222-224.
14. Iyngkaran N., Yadav M., Sinniah M. Augmented inflammatory cytokines in primary dengue infection progressing to shock. Singapore Med. J. 36:1995;218-221.
15. Kimura-Kuroda J., Yasui K. Antigenic comparison of envelope protein E between Japanese encephalitis virus and some other flaviviruses using monoclonal antibodies. J. Gen. Virol. 67:1986;2663-2672.
16. Kuo C. H., Tai D. I., Chien C. S. C., Lan C. K., Chiou S. S., Liaw Y. F. Liver biochemical tests and dengue fever. Am. J. Trop. Med. Hyg. 47:1992;265-270.
17. Kurane I., Ennis F. A. Cytokines in dengue virus infections: Role of cytokines in the pathogenesis of dengue hemorrhagic fever. Semin. Virol. 5:1994;443-448.
18. Kurane I., Ennis F. A. Immunopathogenesis of dengue virus infections. Gubler D. J., Kuno G. Dengue Fever and Dengue Hemorrhagic Fever. 1997;273-290 CAB International, New York.
19. La Russa V. F., Innis B. L. Mechanism of dengue virus-induced bone marrow suppression. Baillier Clin. Haematol. 8:1995;249-270.
20. Lum L. C. S., Lam S. K., Choy Y. S., George R., Harun F. Dengue encephalitis: A true entity. Am. J. Trop. Med. Hyg. 54:1996;256-259.
21. Marianneau P., Megret F., Olivier R., Morens D. M., Deubel V. Dengue 1 virus binding to human hepatoma HepG2 and simian Vero cell surface differs. J. Gen. Virol. 77:1996;2547-2554.
22. Marianneau P., Cardona A., Edelman L., Deubel V., Despres P. Dengue virus replication in human hepatoma cells activates NF-κB which in turn reduces apoptotic cell death. J. Virol. 71:1997;3244-3249.
23. Nimmannitya S., Thisyakorn U., Hemsrichart V. Dengue haemorrhagic fever with unusual manifestations. SE Asian J. Trop. Med. Public Health. 18:1987;398-406.
24. Rajajee S., Mukundan D. Neurological manifestations in dengue hemorrhagic fever. Indian Pediatr. 31:1994;688-690.
25. Rosen L., Khin M. M., Tin U. Recovery of virus from the liver of children with fatal dengue: Reflections on the pathogenesis of the disease and its possible analogy with that of yellow fever. Res. Virol. 140:1989;351-360.
26. Thisyakorn U., Thisyakorn C. Dengue infection with unusual manifestations. J. Med. Assoc. Thai. 77:1994;410-413.
27. Vaughn D. W., Green S., Kalayanarooj S., Innis B. L., Nimmannitya S., Suntayakorn S., Rothman A. L., Ennis F., Nisalak A. Dengue in the early febrile phase: Viremia and antibody responses. J. Infect. Dis. 176:1997;322-330.
28. Wang S. L., He R. T., Patarapotikul J., Innis B. L., Anderson R. Antibody-enhanced binding of dengue 2 virus to human platelets. Virology. 213:1995;254-257.
29. Wu S. J. L, Hayes C. G., Dubois D. R., Windheuser M. G., Kang Y. H., Watts D. M., Sieckmannn D. G. Evaluation of the severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection. Am. J. Trop. Med. Hyg. 52:1995;468-476.
30. Yadav M., Kamath K. R., Iyngkaran N., Sinnich M. Dengue hemorrhagic fever syndrome: Are they tumor necrosis factor-mediated disorders. FEMS Microbiol. Immunol. 4:1991;45-49.